News

ChemDiv is believed to make use of its expertise in drug discovery. Janssen or Tibotec will fund certain R&D costs of ChemDiv for every research project and ChemDiv

Teriflunomide is an immunomodulatory, disease-modifying oral drug with anti-inflammatory properties, and is under investigation as a treatment for MS. The Tenere trial, which was a two-year, randomized, rater-blinded

Zalicus has drawn the remaining $8.5m from its $20m secured credit facility with Oxford Finance to fund ion channel clinical development. Zalicus CEO Mark Corrigan said they look

According to HUMC’s technology consultant, the US hospital will receive an estimated $8m overall in federal stimulus funds, $3m of that in 2011. The 328-bed hospital will receive

Financial terms of the agreement include an upfront fee, clinical and regulatory milestone payments, and royalties on sales. Under the terms of the agreement, CJ CheilJedang is responsible

ForteBio will provide a range of innovative, label-free protein analysis instruments that will extend Pall’s capabilities in the biopharmaceuticals process monitoring market and in the protein research market.

ALKS 9070, a Alkermes molecule, is designed to provide once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available

Under the terms of the deal, Agenus has granted NewVac an exclusive license to manufacture, market and sell Oncophage as well as pursue a development program of Oncophage

According to the researchers, low-cost artemisinin-based drugs are lacking because of the high cost of obtaining the natural or chemically synthesized drug. Owing to tobacco’s high biomass and